TACSTD2 CAR mRNA-LNP
Cat. No.: TDLD-0825-LD43
TACSTD2 CAR mRNA-LNP
TACSTD2 CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting Tumor Associated Calcium Signal Transducer 2 (TACSTD2), serving as an excellent tool for investigating CAR-T cell therapy against TACSTD2-expressing cancers such as ovarian cancer, pancreatic cancer, and colorectal cancer, and studying receptor-specific immune modulation. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of TACSTD2 CAR mRNA-LNP include monitoring CAR expression on transduced T cells and evaluating CAR-T cell functionality against TACSTD2-positive targets. Please note that this product is intended for research purposes only.
| Payload Type | CAR mRNA |
| Payload | TACSTD2 CAR mRNA |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Unconjugation |
| LNP Type | CAR mRNA-LNP |
| Lipid Formulation | SM102 |
| Dye | Unlabeled |
| Application | Gene Therapy; CAR-T |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Click the button below to contact us or submit your feedback about this product.
